Journal: Frontiers in Veterinary Science
Article Title: Advancing the early detection of canine cognitive dysfunction syndrome with machine learning-enhanced blood-based biomarkers
doi: 10.3389/fvets.2024.1390296
Figure Lengend Snippet: RBP4, CXCL10, and NOX4 levels were measured in the plasma from animal groups diagnosed with mild cognitive impairment (MCI) and severe cognitive impairment (SCI) based on CCDR scores. CCDS represents a group inclusive of both MCI and SCI, separated by a dotted line. (A) The bar graphs represent the quantification of RBP4, CXCL10, and NOX4 ELISA levels in each group. Data are mean ± SEM. (B) Representative violin plot graphs of the distribution of biomarker levels in each group. The dot in the graph revealed the distribution of individual samples, and the lines in the violin shape represent quartiles and medians. * , p < 0.05; ** , p < 0.01; *** , p < 0.001; **** , p < 0.0001 vs. each group by a one-way ANOVA. ### , p < 0.001; #### , p < 0.0001 vs. normal by a Student’s two-tailed t -test.
Article Snippet: The following antibodies were used: monoclonal mouse anti-RBP4 antibody (orb751184, Biorbyt, Berkeley, CA, United States); polyclonal rabbit anti-CXCL10 antibody (abx104024, Abbexa, Cambridge, United Kingdom); polyclonal rabbit anti-NOX4 antibody (NB110-58849, Novusbio, Centennial, CO, United States); polyclonal rabbit anti-transferrin antibody (NBP1-97472, Novusbio, Centennial, CO, United States); peroxidase labeled horse anti-mouse IgG (H + L) (7076P2, Cell Signaling Technology, Danvers, MA, United States); peroxidase labeled goat anti-rabbit IgG (H + L) (PI-1000, Vector Laboratories, Burlingame, CA, United States).
Techniques: Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Biomarker Discovery, Two Tailed Test